[Property of a heat- and acid-stable inhibitor of serine proteinases from the blood serum to inhibit lymphcyte transformation stimulated by mitogens].
Thermo- and acid-stable serine proteases inhibitor from the rabbit blood serum (TASPI) was shown to inhibit the human peripheral blood lymphocytes transformation stimulated by phytohemagglutinin (PHA) or concanavalin A. The extent of inhibition depended on the concentration of the preparation and its specific activity. The maximal inhibition of lymphocytes proliferation constituted 50 to 70%. TASPI displayed no cytotoxic activity. Considerably more effective inhibition was demonstrated by TASPI addition to the culture medium 24 hours after the addition of PHA. The antiprotease activity of crude human serum and that inactivated under different conditions is described. The results obtained suggest the participation of TASPI in the control of biological activity of the lymphoid tissue cells.
D000818:Animals; D003208:Concanavalin A / Q000037:antagonists & inhibitors; D004355:Drug Stability; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D037102:Lectins; D008213:Lymphocyte Activation / Q000187:drug effects*; D008934:Mitogens / Q000037:antagonists & inhibitors*; D011480:Protease Inhibitors; D011817:Rabbits; D012694:Serine; D013997:Time Factors
D037102:Lectins; D008934:Mitogens; D011480:Protease Inhibitors; D003208:Concanavalin A; D012694:Serine
Svoĭstvo termo- i kislotostabil'nogo ingibitora serinovykh proteinaz iz syvorotki krovi tormozit' transormatsiiu limfotsitov, stimulirovannykh mitogenami.